ticker
Login
business news
Politics And Regulation
Markets
The Economy
Editor's Pick
trading and investing
Stocks
ETFs
Fixed Income
Earnings
Currencies
Commodities
Options
Taxes
Personal Finance
How To Trade
How To Invest
sectors
Biotech/pharma
Consumer
Energy
Financial
Global Markets
Media
Precious Metals
Real Estate
Technology
Transportation
special features
Wall Of Worry
Random Thoughts
Sports Business
Minyanville Press
Video
Hoofy & Boo
Radio
MV PREMIUM
subscriptions
Launch Buzz And Banter
Buzz And Banter
Elliott Wave Insider
Tchir's Fixed Income Report
Cooper's Market Report
Techstrat Report
Optionsmith
The Stock Playbook
Ad Free Minyanville
Minyanville Book Store
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
Sanofi-Aventis ADS
(NY:
SNY
)
54.86
USD
+0.30 (+0.55%)
Official Closing Price
/ Updated:
6:40 PM EDT, May 24, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Research
Quarterly Reports
Insider Filings
Other Filings
Stories about Sanofi-Aventis ADS
< Previous
1
2
3
4
5
6
7
8
9
...
93
94
Next >
4 Contagion Plays
May 23, 2013
In late March news out of China revealed that a new strain of bird flu was spreading to humans. Medical experts worldwide were alarmed, but it barely registered among investors—especially in the U.S....
Read More
category
NYSE:NVS
,
NYSE:SNY
,
NYSE:GSK
, and 1 more.
from
Forbes Real Time
Sanofi-Aventis: 52-Week High Recently Eclipsed (SNY)
May 22, 2013
from
Comtex SmarTrend® News Briefs
New Asthma Drug Generates Excitement For Patients -- And Its Maker
May 21, 2013
Read More
category
NYSE:MRK
,
NYSE:SNY
,
NASDAQ:REGN
, and 1 more.
from
Forbes Real Time
Sanofi (SNY), Regeneron (REGN) Report Publication of Positive Dupilumab Phase 2a Data
May 21, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8357210 for the full story.
Read More
from
StreetInsider.com News Articles
New Asthma Drug Could Be Game Changer
May 21, 2013
Read More
category
NYSE:SNY
,
NASDAQ:REGN
,
Hot Stocks
from
InvestorPlace - Latest Headlines
Microsoft (MSFT) Flat Into Reveal of Next-Gen Xbox
May 20, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8354613 for the full story.
Read More
from
StreetInsider.com News Articles
Sanofi (SNY) Reports JAKARTA Met Primary Endpoint in Both Groups
May 17, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8349866 for the full story.
Read More
from
StreetInsider.com News Articles
Finding the Next Big Blockbuster Drug
May 15, 2013
from
ACCESSWIRE
Buffett's Berkshire Hathaway Enters Chicago Bridge & Iron (CBI), Sells Archer-Daniels-Midland (ADM), General Dynamics (GD)
May 15, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8343832 for the full story.
Read More
from
StreetInsider.com News Articles
Sanofi (SNY), Regeneron (REGN) Commence COMPARE, ASCERTAIN of Sarilumab
May 15, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8339115 for the full story.
Read More
from
StreetInsider.com News Articles
Europe stocks slip after Chinese inflation data
May 09, 2013
European stock markets retreat after two positive trading days on Thursday, after higher-than-expected Chinese inflation data stoke fears the government will withhold more easing measures.
Read More
category
DX:DAX
,
Financial Services
,
Banks
, and 16 more.
from
MarketWatch
Top 4 NYSE Stocks In The Drug Manufacturers-Major Industry With The Lowest PEG Ratio
May 08, 2013
Below are the top drug manufacturers-major stocks on the NYSE in terms of PEG ratio. WuXi PharmaTech (Cayman) (NYSE: WX ) has a PEG ratio of 1.12. WuXi PharmaTech's trailing-twelve-month revenue is...
Read More
category
Benzinga
,
JNJ
,
WX
, and 6 more.
from
Latest Articles from Benzinga.com
Big Profits in Big Pharma
May 06, 2013
Don't let the less-than-stellar first quarter performances of a few well-known drug makers spook you: "Big Pharma" is a good investment over the long haul.
Read More
from
Update Content Feed for Financial Content
PPH, SNY, GSK, AZN: ETF Outflow Alert
May 03, 2013
Symbols mentioned in this story: PPH, SNY, GSK, AZN Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These ''units''...
Read More
category
ETFs
from
ETF Channel
Watch for Continued Gains in Shares of Sanofi-Aventis (SNY)
May 03, 2013
from
Comtex SmarTrend® News Briefs
Fear on the Floor Ahead of Jobs Report
May 02, 2013
Initial jobless claims may have hit a five-year low this morning, but there's a lot of fear about Friday's jobs report. Bears are already saying this could be the report that finally forces the markets...
Read More
category
Marriott International Inc
,
Cigna Corp
,
Merck & Co Inc
, and 6 more.
from
CNBC.com News
US Stocks Seen Lower; ECB Eyed
May 02, 2013
U.S. stock index futures signaled a lower open on Thursday, as weak manufacturing data knocked investor confidence in Asia and Europe.
Read More
category
Siemens AG
,
Economics
,
STATOIL ASA
, and 16 more.
from
CNBC.com News
Europe stocks cautious as ECB decision looms
May 02, 2013
European stock markets traded mostly lower on Thursday as markets await a potential rate cut from the ECB. Statoil, Sanofi and Infineon all react to results.
Read More
category
Earnings
,
Banks
,
FR:BNP
, and 42 more.
from
MarketWatch
Europe Stocks to Dip Ahead of ECB Decision
May 02, 2013
European shares are expected to open lower on Thursday ahead of a rate decision by the European Central Bank (ECB).
Read More
category
Siemens AG
,
Randgold Resources Limited
,
STATOIL ASA
, and 5 more.
from
CNBC.com News
Regeneron Pharmaceuticals: The Stock That Only Goes Up?
May 01, 2013
Shares of Regeneron Pharmaceuticals (NASDAQ: REGN ) were trading at new all-time high levels on Wednesday afternoon on concerns that rival Allergan (NYSE: AGN ) may have problems moving its unnamed...
Read More
category
Benzinga
,
REGN
,
Movers
, and 10 more.
from
Latest Articles from Benzinga.com
Ampio Pharma Initiates Phase III, Investors Extend Momentum
May 01, 2013
Ampio Pharma Initiates Phase III, Investors Extend Momentum Shares of Ampio Pharmaceuticals (NASDAQ: AMPE) are on a roll after the company reported on April 24th that they had completed enrollment for...
Read More
category
Prime Content
,
Bio/Wire
,
AMPE
from
Bio-Wire.Com
Genzyme’s former CEO takes board seat at Moderna
April 30, 2013
category
Genzyme Corp/
,
Moderna
,
Biotech
, and 10 more.
from
Business Journals
Wall Street Gets It Backward On Amgen Cholesterol Drug
April 29, 2013
Shares of Aegerion Pharmaceuticals have risen 200% since October on hopes that the company’s drug Juxtapid, a treatment for a rare genetic disease that causes super-high cholesterol and early heart...
Read More
category
NYSE:SNY
,
NASDAQ:REGN
,
NASDAQ:ISIS
, and 2 more.
from
Forbes Real Time
Technical Briefing on SNY, VVUS, ACUR, and NSPH
April 29, 2013
from
ACCESSWIRE
Europe stocks bid higher, with Italy in the lead
April 29, 2013
European stocks push higher on Monday, with pharmaceutical companies and banks providing support and Italian stocks in the lead as the market cheers a new government. Earnings new drives Rentokil...
Read More
category
Earnings
,
DX:DAX
,
Financial Services
, and 24 more.
from
MarketWatch
Week in Review: WuXi PharmaTech Contributes to Syros Pharma Funding
April 27, 2013
Syros Pharmaceuticals of Boston raised $30 million to develop cancer treatments from WuXi PharmaTech and other investors; a subsidiary of Hua Han Bio-Pharma signed a framework agreement to set up a JV...
Read More
from
ChinaBio® Today
Fed May Provide a Safety Net for the Market
April 26, 2013
The Fed is expected to repeat its dovish message in the coming week, which could provide a safety net for the market amid a big wave of earnings and the important April jobs report.
Read More
category
Realogy Corp
,
Archer Daniels Midland Co
,
tvcodes/tvearn
, and 94 more.
from
CNBC.com News
Cancer Doctors Raise Pressure On Pharma Industry To Cut Drug Prices
April 25, 2013
In the latest flap over the high cost of cancer medicines, nearly 120 physicians from 15 countries have authored a commentary in a medical journal in which they call for drugmakers to lower their...
Read More
category
NYSE:NVS
,
NYSE:SNY
from
Forbes Real Time
In Moribund Cholesterol Field, A New Drug Emerges
April 25, 2013
The artery disease that leads to heart attacks and strokes is the biggest killer in the United States. But when it comes to new drugs in development, atherosclerosis is dwarfed by cancer and...
Read More
category
NYSE:SNY
,
NYSE:PFE
,
NASDAQ:ISIS
, and 2 more.
from
Forbes Real Time
Genzyme Announces Positive Top-Line Results from TOPIC Trial for AUBAGIO
April 25, 2013
Genzyme, a Sanofi company (NYSE: SNY ), announced today positive top-line results from the TOPIC trial for AUBAGIO (teriflunomide). The trial was designed to assess whether early initiation
Read More
category
Contracts
,
Management
,
Benzinga
, and 4 more.
from
Latest Articles from Benzinga.com
< Previous
1
2
3
4
5
6
7
8
9
...
93
94
Next >
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here
Stay Connected
WHAT'S POPULAR IN THE VILLE
1
Google and NASA Make Quantum Leap With New Computer
Josh Wolonick
2
Random Thoughts: The Third Dip Cometh!
Todd Harrison
3
Google, Facebook, Yahoo, and Twitter: Web Giants Make Unexpected Announcements
Carol Kopp
4
Mother of All Fed Cha-Cha Days or Last Tango on Wall Street?
Jeffrey Cooper
5
Random Thoughts: A Signal That Bears Watching
Todd Harrison
See All Articles
»